Structure determination of chiral sulfoxide in diastereomeric bicalutamide derivatives

Chirality

Volumn 21, Issue 6, 2009, Pages 578-583

  Li, Wei ^a   Hwang, Dong Jin ^a   Cremer, Dieter ^b   Joo, Hyun ^b   Kraka, Elfi ^b   Kim, Juhyun ^c   Ross II, Charles R ^d   Nguyen, Viet Q ^a   Dalton, James T ^c   Miller, Duane D ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Androgen receptor antagonists; NMR; Quantum chemical calculations; Sulfoxide; X ray crystal structure

Indexed keywords

BICALUTAMIDE; CARBON; CHIRAL SULFOXIDE; PROTON; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SULFOXIDE; UNCLASSIFIED DRUG; ANDROGEN RECEPTOR; ANILIDE; DRUG DERIVATIVE; NITRILE; SAFROLE; TOLUENESULFONIC ACID DERIVATIVE;

ARTICLE; ATOM; CRYSTAL STRUCTURE; DIASTEREOISOMER; DRUG STRUCTURE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUANTUM CHEMISTRY; STRUCTURE ANALYSIS; X RAY ANALYSIS; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUANTUM THEORY; STEREOISOMERISM; X RAY CRYSTALLOGRAPHY;

ANILIDES; CRYSTALLOGRAPHY, X-RAY; MAGNETIC RESONANCE SPECTROSCOPY; NITRILES; QUANTUM THEORY; RECEPTORS, ANDROGEN; SAFROLE; STEREOISOMERISM; TOSYL COMPOUNDS;

EID: 67649410681     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.20642     Document Type: Article

References (40)

1. Gadepalli RSVS, Rimoldi JM, Fronczek FR, Nillos M, Gan J, Deng X, Rodriguez-Fuentes G, Schlenk D. Synthesis of fenthion sulfoxide and fenoxon sulfoxide enantiomers: effect of sulfur chirality on acetylcholinesterase activity. Chem Res Toxicol 2007;20:257-262.
2. Pellissier H. Use of chiral sulfoxides in asymmetric synthesis. Tetrahedron 2006;62:5559-5601.
3. Bentley R. Role of sulfur chirality in the chemical processes of biology. Chem Soc Rev 2005;34:609-624.
4. Fernandez I, Khiar N. Recent developments in the synthesis and utilization of chiral sulfoxides. Chem Rev (Washington, DC) 2003;103: 3651-3705.
5. Solladie G. Applications of chiral sulfoxides in enantioselective synthesis of diols and total synthesis of natural products. Heteroatom Chem 2002;13:443-452.
6. Donnoli MI, Giorgio E, Superchi S, Rosini C. Circular dichroism spectra and absolute configuration of some aryl methyl sulfoxides. Org Biomol Chem 2003;1:3444-3449.
7. Stephens PJ, Devlin FJ, Cheeseman JR, Frisch MJ, Rosini C. Determination of absolute configuration using optical rotation calculated using density functional theory. Org Lett 2002;4:4595-4598.
8. Devlin FJ, Stephens PJ, Scafato P, Superchi S, Rosini C. Determination of absolute configuration using vibrational circular dichroism spectroscopy: the chiral sulfoxide 1-thiochromanone S-oxide. Chirality 2002;14:400-406.
9. Devlin FJ, Stephens PJ, Scafato P, Superchi S, Rosini C. Conformational analysis using infrared and vibrational circular dichroism spectroscopies: the chiral cyclic sulfoxides 1-thiochroman-4-one S-oxide, 1-thiaindan s-oxide and 1-thiochroman S-oxide. J Phys Chem A 2002; 106:10510-10524.
10. Stephens PJ, Aamouche A, Devlin FJ, Superchi S, Donnoli MI, Rosini C. Determination of absolute configuration using vibrational circular dichroism spectroscopy: the chiral sulfoxide 1-(2-methylnaphthyl) methyl sulfoxide. J Org Chem 2001;66:3671-3677.
11. Donnoli MI, Superchi S, Rosini C. Chromatographic resolution and elution order of alkyl aryl and aryl benzyl sulfoxides on cellulose-based chiral stationary phases. Enantiomer 2000;5:181-188.
12. Yabuuchi T, Kusumi T. NMR Spectroscopic determination of the absolute configuration of chiral sulfoxides via N-(methoxyphenylacetyl) sulfoximines. J Am Chem Soc 1999;121:10646-10647.
13. Kusumi T, Ooi T, Ohkubo Y, Yabuuchi T. The modified Mosher's method and the sulfoximine method. Bull Chem Soc Jpn 2006;79:965-980.
14. Chen J, Hwang DJ, Bohl CE, Miller DD, Dalton JT. A selective androgen receptor modulator for hormonal male contraception. J Pharmacol Exp Ther 2005;312:546-553.
15. Matsumoto AM. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. J Clin Endocrinol Metab 1990;70:282-287.
16. Tucker H, Chesterson GJ. Resolution of the nonsteroidal antiandrogen 4′-cyano-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3′- (trifluoromethyl)-propionanilide and the determination of the absolute configuration of the active enantiomer. J Med Chem 1988;31:885-887.
17. Van Dort ME, Robins DM, Wayburn B. Design, synthesis, and pharmacological characterization of 4-[4, 4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]- 2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand. J Med Chem 2000;43:3344-3347.
18. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
19. Schroder FH, Whelan P, de Reijke TM, Kurth KH, Pavone-Macaluso M, Mattelaer J, van Velthoven RF, Debois M, Collette L. Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892. Eur Urol 2004;45:457-464.
20. Kassouf W, Tanguay S, Aprikian AG. Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails. J Urol 2003;169:1742-1744.
21. Dukes M, Furr BJ, Hughes LR, Tucker H, Woodburn JR. Nonsteroidal progestins and antiprogestins related to flutamide. Steroids 2000; 65:725-731.
22. Schellhammer PF, Davis JW. An evaluation of bicalutamide in the treatment of prostate cancer. Clin Prostate Cancer 2004;2:213-219.
23. James KD, Ekwuribe NN. A two step synthesis of the anti-cancer drug (R, S)-bicalutamide Synthesis. Synthesis 2002;7:850-852.
24. Dalton JT, Mukherjee A, Zhu Z, Kirkovsky L, Miller DD. Discovery of nonsteroidal androgens. Biochem Biophys Res Commun 1998;244:1-4.
25. Hwang DJ, Yang J, Xu H, Rakov IM, Mohler ML, Dalton JT, Miller DD. Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer. Bioorg Med Chem 2006;14:6525-6538.
26. Marhefka CA, Gao W, Chung K, Kim J, He Y, Yin D, Bohl C, Dalton JT, Miller DD. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators. J Med Chem 2004;47:993-998.
27. Kirkovsky L, Mukherjee A, Yin D, Dalton JT, Miller DD. Chiral nonsteroidal affinity ligands for the androgen receptor. I. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring. J Med Chem 2000;43:581-590.
28. Mukherjee A, Kirkovsky LI, Kimura Y, Marvel MM, Miller DD, Dalton JT. Affinity labeling of the androgen receptor with nonsteroidal chemoaffinity ligands. Biochem Pharmacol 1999;58:1259-1267.
29. Dewar MJS, Reynolds CH. An improved set of mndo parameters for sulfur. J Comput Chem 1986;7:140-143.
30. Becke AD. Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 1993;98:5648-5652.
31. Lee C, Yang W, Parr RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 1988;37:785-789.
32. Francl MM, Pietro WJ, Hehre WJ, Binkley JS, Gordon MS, DeFrees DJ, Pople JA. Self-consistent molecular orbital methods. XXIII. A polarization-type basis set for second-row elements. J Chem Phys 1982; 77:3654-3665.
33. Hariharan PC, Pople JA. Influence of polarization functions on MO hydrogenation energies. Theo Chim Acta 1973;28:213-222.
34. Cossi M, Rega N, Scalmani G, Barone V. Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model. J Comput Chem 2003;24:669-681.
35. Olsson L, Cremer D. Prediction of nitrogen and oxygen NMR chemical shifts in organic compounds by density functional theory. J Phys Chem 1996;100:16881-16891.
36. 17O nuclear magnetic resonance chemical shifts. J Chem Phys 1996;105:8995-9006.
37. Malkin VG, Malkina OL, Casida ME, Salahub DR. Nuclear magnetic resonance shielding tensors calculated with a sum-over-states density functional perturbation theory. J Am Chem Soc 1994;116:5898-5908.
38. Kraka E, Grafenstein J, Filatov M, Joo H, Izotov D, Gauss J, He Y, Wu A, Polo V, Olsson L, Konkoli Z, He Z, Cremer D. COLOGNE07. Stockton, CA: University of Pacific; 2007.
39. Sheldrick GM SHELXS-97. University of Gottingen, Germany; 1990.
40. Sheldrick GM SHELXL-97. University of Gottingen, Germany; 1997.